Medicine & Health

Fewer than half of people worldwide who have already had one heart attack or stroke take daily aspirin to prevent a second one, according to a new study led by researchers at the School of Medicine. Increasing daily aspirin use in such patients could reduce cardiovascular deaths.

Siyuan Ding, an assistant professor of molecular microbiology at the School of Medicine, has received the 2023 Ann Palmenberg Junior Investigator Award from the American Society of Virology.

For people who have contracted the COVID-19 virus, pain and suffering may continue two years after infection, according to a new study from the School of Medicine and the Veterans Affairs St. Louis Health Care system.

Washington University School of Medicine’s Alpha Omega Alpha chapter has chosen 24 faculty members, alumni and house officers-in-training to be new members of the medical honor society.

Philip R.O. Payne, at the School of Medicine, has joined the steering committee of a National Academy of Medicine working group to draft a code of conduct for artificial intelligence in health, medical care and health research.

Scientists at Washington University have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and provides results in less than a minute.

Ismael Seáñez at the McKelvey School of Engineering is developing a new method to treat spinal cord injuries that uses a low-tech electrode array that effectively stimulates muscles in the legs in people with spinal cord injuries.

Philip Bayly and Jordan Escarcega at the McKelvey School of Engineering led a multi-institutional team to compare how the human brain deforms in response to movement using two types of magnetic resonance imaging. Such deformations are key to understanding traumatic brain injury but are challenging to study since the brain is hidden inside the skull.

The Division of Physician-Scientists at the School of Medicine has named its 2023 Dean’s Scholars. The awardees will receive up to two years of financial support and mentorship, as well as dedicated lab time to conduct scientific research.

David T. Curiel, MD, PhD, and Michael S. Diamond, MD, PhD, both of the School of Medicine, have received the Chancellor’s Award for Innovation and Entrepreneurship for their development of a nasal vaccine against the virus that causes COVID-19.